Form 4: JPMorgan Co-CEO Sells 50,000 Shares Under 10b5-1 Plan
Insider Transaction Report
JPMorgan Chase & Co. Co-CEO of CIB, Troy L. Rohrbaugh, reported the sale of 50,000 shares of common stock at $307.1134 per share.
Summary
- Troy L. Rohrbaugh, Co-CEO of Corporate & Investment Bank (CIB) at JPMorgan Chase & Co. (JPM), reported a transaction.
- On February 19, 2026, Rohrbaugh disposed of 50,000 shares of JPM common stock.
- The shares were sold at a price of $307.1134 per share.
- This transaction was executed pursuant to a Rule 10b5-1(c) contract, instruction, or written plan.
- Following the reported transaction, Rohrbaugh directly beneficially owns 111,279 shares of common stock.
- Additionally, Rohrbaugh indirectly beneficially owns 92.3743 shares through a 401(k) plan.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral event. The insider sale, while significant in volume, is a routine transaction for an executive, especially given its execution under a pre-arranged 10b5-1 plan, and does not inherently signal a change in the company's fundamental outlook.
Positives
- The transaction was made pursuant to a Rule 10b5-1(c) plan, which indicates a pre-arranged sale and can mitigate concerns about opportunistic insider trading.
Negatives
- A significant sale of 50,000 shares by a high-ranking executive could be interpreted by some as a lack of confidence, although this is often offset by the 10b5-1 plan.
Future Outlook
This filing does not contain any forward-looking statements or guidance regarding the company's future performance.
Industry Context
StockSavvy.ai notes that insider sales, particularly by high-ranking executives, are common for personal financial planning, diversification, or liquidity. When executed under a Rule 10b5-1 plan, such transactions are pre-scheduled, reducing the perception of opportunistic trading based on non-public information. For a financial institution of JPMorgan Chase's size, such a transaction by a Co-CEO is generally viewed as a routine event rather than a signal of fundamental change.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Insider Trading Policy Adherence | The transaction was conducted under a Rule 10b5-1(c) plan, which is a mechanism designed to allow insiders to sell company stock without being accused of insider trading, by pre-scheduling trades. | 02/19/2026 | Demonstrates adherence to corporate governance best practices regarding insider trading compliance, ensuring transactions are pre-planned and not based on material non-public information. |
Stakeholder Impact
- Shareholders: Minimal direct impact on the broader shareholder base, as the sale represents a very small fraction of JPMorgan Chase & Co.'s total outstanding shares and is likely part of routine executive financial management.
- Employees, Customers, Suppliers, Creditors: No direct impact from this specific insider transaction.
Key Dates
| Date | Description |
|---|---|
| 02/19/2026 | Date of transaction for the sale of 50,000 shares of common stock by Troy L. Rohrbaugh. |
Recommendation
holdThe reported insider sale by a Co-CEO is a routine event, often for personal financial planning or diversification, especially given it was executed under a Rule 10b5-1 plan. It does not provide new fundamental information about JPMorgan Chase & Co. that would alter an investment thesis for a seasoned investor or institution. Therefore, a 'hold' recommendation is appropriate as the core investment rationale remains unchanged by this disclosure.
Keywords
JPM, JPMorgan Chase, insider trading, Form 4, stock sale, executive compensation, Troy L. Rohrbaugh, 10b5-1 plan
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.